Log in

Relevant bibliographies by topics / Toxicologic pathology / Journal articles

To see the other types of publications on this topic, follow the link: Toxicologic pathology.

Journal articles on the topic 'Toxicologic pathology'

Author: Grafiati

Published: 4 June 2021

Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Toxicologic pathology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Boyle, Molly H., Bindu Bennet, Karyn Colman, Anna-Lena Frisk, Begonya Garcia, Christopher D. Houle, Annette Romeike, Radhakrishna Sura, Jonathan Werner, and Susan A. Elmore. "Publication Categories in Toxicologic Pathology." Toxicologic Pathology 49, no. 5 (February 12, 2021): 1042–47. http://dx.doi.org/10.1177/0192623321992305.

Full text

Abstract:

Toxicologic Pathology is the official journal of the Society of Toxicologic Pathology (STP), the British Society of Toxicological Pathology, and the European STP (ESTP). Toxicologic Pathology publishes articles related to topics in various aspects of toxicologic pathology such as anatomic pathology, clinical pathology, experimental pathology, and biomarker research. Publications include society-endorsed Best Practice/Position and Points to Consider publications and ESTP Expert Workshop articles that are relevant to toxicologic pathology and scientific regulatory processes, Opinion articles under the banner of the STP Toxicologic Pathology Forum, Original Articles, Review Articles (unsolicited/contributed, mini, and invited), Brief Communications, Letters to the Editor, Meeting Reports, and Book Reviews. This article provides details on the various publication categories in Toxicologic Pathology and will serve as a reference for authors and readers.

APA, Harvard, Vancouver, ISO, and other styles

2

Cohen, Samuel M., Wanda M. Haschek-Hock, and Carl Alden. "Obituary: Dr Gordon Charles Hard (1931-2021)." Toxicologic Pathology 50, no. 2 (January 8, 2022): 164–65. http://dx.doi.org/10.1177/01926233211068853.

Full text

Abstract:

Dr Gordon Hard, of Tairua, New Zealand, a preeminent international toxicology thought leader and international consultant in toxicologic pathology of the kidney, passed on November 22, 2021. He was a key player in shaping and developing the global field of toxicologic pathology and the role of toxicologic pathology in risk assessment of environmental chemicals and pharmaceuticals.

APA, Harvard, Vancouver, ISO, and other styles

3

Schwetz, Bernard A. "Toxicologic Pathology: Looking Ahead." Toxicologic Pathology 31, no. 1_suppl (January 2003): 2–5. http://dx.doi.org/10.1080/01926230390174869.

Full text

Abstract:

The field of toxicologic pathology is being impacted, as are other fields of science and medicine, by rapid transitions to take advantage of new science and technology. The new technology represents great opportunities to advance our understanding of toxicology and pathology to exciting new levels, but it also poses new challenges. We must be seriously engaged in that transition to assure that the outcome reflects the knowledge and discipline that are hallmarks of today's decision-making process in areas of product development and approval. New expertise will be required to deal with new issues. How well and how rapidly we adapt as the field moves from “... icities” to “ ... omics” will, at least in part, determine the role of toxicologic pathologists in the product development and approval processes of the future.

APA, Harvard, Vancouver, ISO, and other styles

4

Bolon (Chair), Brad, Erio Barale-Thomas, Alys Bradley, Robert A. Ettlin, Carla A. S. Franchi, Catherine George, Anna Maria Giusti, et al. "International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-type, Nonclinical Toxicity Studies." Toxicologic Pathology 38, no. 6 (August 17, 2010): 984–92. http://dx.doi.org/10.1177/0192623310378137.

Full text

Abstract:

The International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type, nonclinical toxicology studies. Optimally, trainees should undertake a scientific curriculum of at least five years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain four or more years of intensive pathology practice during a residency and/or on-the-job “apprenticeship,” at least two years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A nonclinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one’s understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies.

APA, Harvard, Vancouver, ISO, and other styles

5

Gauthier, Béatrice E., Frédéric Gervais, Gregory Hamm, Donal O’Shea, Alain Piton, and Vanessa L. Schumacher. "Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework." Toxicologic Pathology 47, no. 4 (February 5, 2019): 436–43. http://dx.doi.org/10.1177/0192623319827485.

Full text

Abstract:

Digital pathology is defined as the ability to examine digitized microscopic slides and to generate qualitative and quantitative data. The field of digital pathology is rapidly evolving and has the potential to revolutionize toxicologic pathology. Techniques such as automated 2-D image analysis, whole slide imaging, and telepathology are already considered “mature” technologies and have been used for decades in exploratory studies; however, many organizations are reluctant to use digital pathology in regulatory toxicology studies. Innovative technologies using digitized slides including high-content imaging modalities and artificial intelligence are still under development but are increasingly used in toxicologic pathology. While software validation requirements are already described, clear guidance for application of these rules to the digital pathology field are few and the acceptance of these technologies by regulatory authorities remains necessary for successful adoption of digital pathology into the mainstream of toxicologic pathology. This topic was discussed during a roundtable at the 2018 Annual Congress of the French Society of Toxicologic Pathology. This opinion article summarizes the discussion regarding the current questions and challenges on the integration of innovative digital pathology tools within a good laboratory practice framework and is meant to stimulate further discussion among the toxicologic pathology community. [Box: see text]

APA, Harvard, Vancouver, ISO, and other styles

6

Dagli, Maria L. Z., Arun Pandiri, Jeff Wolf, Sibylle Groeters, and Wanda M. Haschek-Hock. "Global Perspective on Careers in Environmental Toxicologic Pathology: The 2019 Society of Toxicologic Pathology Annual Symposium Lunchtime Career Development Session." Toxicologic Pathology 47, no. 8 (September 25, 2019): 1088–95. http://dx.doi.org/10.1177/0192623319877859.

Full text

Abstract:

A wide range of career options is available globally in the environmental toxicologic pathology (ETP) arena including academia, government, contract research organizations, and the agrichemical/chemical industry. This small and specialized subset of toxicologic pathologists addresses the effects of contaminants and pollutants on human, animal, and ecological health (One Health). Veterinary students and pathology trainees are primarily exposed to diagnostic pathology and often have limited exposure to toxicologic pathology and even less so to the issues and opportunities in environmental toxicology. The speakers provided a brief overview of global opportunities in their work sector and personal perspectives of their careers in ETP. The following panel discussion provided an opportunity to discuss issues related to careers in this specialty.

APA, Harvard, Vancouver, ISO, and other styles

7

Prasse, Keith, Paul Hildebrandt, and David Dodd. "In Toxicologic Pathology." Toxicologic Pathology 14, no. 2 (February 1986): 274–75. http://dx.doi.org/10.1177/019262338601400218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Haschek-Hock, Wanda M. "Diagnostic Toxicologic Pathology." Toxicologic Pathology 20, no. 3-1 (May 1992): 454–55. http://dx.doi.org/10.1177/019262339202000316.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hubbs, Ann F., Linda M. Sargent, Dale W. Porter, Tina M. Sager, Bean T. Chen, David G. Frazer, Vincent Castranova, et al. "Nanotechnology: Toxicologic Pathology." Toxicologic Pathology 41, no. 2 (February 2013): 395–409. http://dx.doi.org/10.1177/0192623312467403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Maronpot, Robert R., and Maria L. Z. Dagli. "Contemporary Activities of Toxicologic Pathology Societies." Toxicologic Pathology 48, no. 2 (October 23, 2019): 295–301. http://dx.doi.org/10.1177/0192623319880885.

Full text

Abstract:

Educational activities and training opportunities in toxicologic pathology are major goals of 9 formally established Toxicologic Pathology Societies and the International Academy of Toxicologic Pathology. Some Toxicologic Pathology Societies have examination-based certification programs while others accept certification or registration by veterinary pathology organizations including the American College of Veterinary Pathologists, the European College of Veterinary Pathologists. We summarize here the membership numbers and current activities of formally established Toxicologic Pathology Socities.

APA, Harvard, Vancouver, ISO, and other styles

11

King, Gregory S. "Handbook of Toxicologic Pathology." Archives of Pathology & Laboratory Medicine 126, no. 9 (September 1, 2002): 1138–39. http://dx.doi.org/10.5858/2002-126-1138b-hotp.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Schwetz, Bernard A. "Toxicologic Pathology: Looking Ahead." Toxicologic Pathology 31, no. 1 (January 1, 2003): 2–5. http://dx.doi.org/10.1080/01926230309772.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ross, Tony. "Fundamentals of Toxicologic Pathology." Australian Veterinary Journal 88, no. 6 (June 2010): 235. http://dx.doi.org/10.1111/j.1751-0813.2010.00594.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

B.M.W. "Immunopathology and toxicologic pathology." Human Pathology 18, no. 4 (April 1987): 315–16. http://dx.doi.org/10.1016/s0046-8177(87)80158-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Zimmerman, Shantay. "Handbook of Toxicologic Pathology." Pathology 25, no. 3 (1993): 326. http://dx.doi.org/10.1016/s0031-3025(16)35643-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Ward, J. M. "Book Review: Toxicologic Pathology." Veterinary Pathology 56, no. 5 (June 24, 2019): 807. http://dx.doi.org/10.1177/0300985819858945.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Hayes, A. Wallace, and Darlene Dixon. "Cornerstones of Toxicology." Toxicologic Pathology 45, no. 1 (January 2017): 57–63. http://dx.doi.org/10.1177/0192623316675768.

Full text

Abstract:

The 35th Annual Society of Toxicologic Pathology Symposium, held in June 2016 in San Diego, California, focused on “The Basis and Relevance of Variation in Toxicologic Responses.” In order to review the basic tenants of toxicology, a “broad brush” interactive talk that gave an overview of the Cornerstones of Toxicology was presented. The presentation focused on the historical milestones and perspectives of toxicology and through many scientific graphs, data, and real-life examples covered the three basic principles of toxicology that can be summarized, as dose matters (as does timing), people differ, and things change (related to metabolism and biotransformation).

APA, Harvard, Vancouver, ISO, and other styles

18

Sharma, Alok K., James P. Morrison, Deepa B. Rao, Ingrid D. Pardo, Robert H. Garman, and Brad Bolon. "Toxicologic Pathology Analysis for Translational Neuroscience." International Journal of Toxicology 35, no. 4 (March 24, 2016): 410–19. http://dx.doi.org/10.1177/1091581816636372.

Full text

Abstract:

A half-day American College of Toxicology continuing education course presented key issues often confronted by translational neuroscientists when predicting human risk from animal-derived toxicologic pathology data. Two talks correlated discrete structures with major functions in brains of rodents and nonrodents. The third lecture provided practical advice to obtain highly homologous rodent brain sections for quantitative morphometry in developmental neurotoxicity testing. The last presentation discussed demographic influences (eg, species, strain, sex, age), physiological attributes (eg, body composition, brain vascularity, pharmacokinetic/pharmacodynamic patterns, etc), and husbandry parameters (eg, group housing) recognized to impact the actions of neuroactive chemicals. Speakers described common cases of real-world challenges to animal data interpretation encountered when designing studies or extrapolating biological responses across species. The efficiency of translational neuroscience efforts will likely be enhanced as new methods (eg, high-resolution non-invasive imaging) improve our capability to cross-connect subtle anatomic and/or biochemical lesions with functional changes over time.

APA, Harvard, Vancouver, ISO, and other styles

19

Rudmann, Daniel G. "The Emergence of Microphysiological Systems (Organs-on-chips) as Paradigm-changing Tools for Toxicologic Pathology." Toxicologic Pathology 47, no. 1 (November 8, 2018): 4–10. http://dx.doi.org/10.1177/0192623318809065.

Full text

Abstract:

Microphysiological systems (MPS), commonly known as organs-on-chips, are a rapidly advancing technology that promises to impact many areas of medical and toxicological pathology. In this minireview, the history of MPS and its potential utility in safety assessment are described with the toxicologic pathologist in mind. Several MPS development focus areas are defined, and recent progress in the area is highlighted. MPS will likely become an important tool for the toxicologic pathologist as part of our role in the safety assessment process within the pharmaceutical, biotechnology, medical device, and cosmetic and agrichemical industries.

APA, Harvard, Vancouver, ISO, and other styles

20

Carreira, Vinicius, Gopinath Palanisamy, Erin Quist, Keith Nelson, Stacey Fossey, Bevin Zimmerman, Lila Ramaiah, and Kenneth A. Schafer. "Practical Strategies for Navigating Toxicologic Pathology in One’s Early Career…and Beyond!" Toxicologic Pathology 46, no. 8 (October 23, 2018): 1037–48. http://dx.doi.org/10.1177/0192623318805716.

Full text

Abstract:

The toxicologic pathologist plays a vital role in the scientific community, using their unique blend of diagnostic and investigative skills to advance biomedical research, public health, drug discovery, or regulatory practices. But what exactly do toxicologic pathologists contribute? Where do these specialized professionals work? How can toxicologic pathologists maximize their efficiency and potential? To enlighten students and trainees, as well as early- or mid-career toxicologic pathologists, or even those approaching retirement, the Career Development and Outreach Committee of the Society of Toxicologic Pathology (STP) sponsored a career development workshop entitled “Practical Strategies for Navigating Toxicologic Pathology in One’s Early Career…and Beyond!” in conjunction with the STP 37th annual symposium. The workshop featured toxicologic pathologists from contract research organizations and the pharmaceutical industry, who provided their perspectives on career preparation, evolving veterinary pathologist roles within various sectors of toxicologic pathology, the fundamentals of safety assessment, logistics of projects involving good laboratory practices, tools for effective interpretation and communication of anatomic and clinical pathology results, and a recap of scientific resources available to support the toxicologic pathologist in his or her journey. This article provides brief summaries of the talks presented during this career development workshop.

APA, Harvard, Vancouver, ISO, and other styles

21

Harrill, Alison H., Jonathan G. Moggs, Karissa K. Adkins, Hellmut G. Augustin, Robert C. Johnson, and Michael W. Leach. "A Synopsis of the “Influence of Epigenetics, Genetics, and Immunology” Session Part A at the 35th Annual Society of Toxicologic Pathology Symposium." Toxicologic Pathology 45, no. 1 (October 5, 2016): 114–18. http://dx.doi.org/10.1177/0192623316670781.

Full text

Abstract:

The overarching theme of the 2016 Society of Toxicology Pathology’s Annual Symposium was “The Basis and Relevance of Variation in Toxicologic Responses.” Session 4 focused on genetic variation as a potential source for variability in toxicologic responses within nonclinical toxicity studies and further explored how knowledge of genetic traits might enable targeted prospective and retrospective studies in drug development and human health risk assessment. In this session, the influence of both genetic sequence variation and epigenetic modifications on toxicologic responses and their implications for understanding risk were explored. In this overview, the presentations in this session will be summarized, with a goal of exploring the ramifications of genetic and epigenetic variability within and across species for toxicity studies and disseminating information regarding novel tools to harness this variability to advance understanding of toxicologic responses across populations.

APA, Harvard, Vancouver, ISO, and other styles

22

Hardisty, Jerry F. "Classic Examples in Toxicologic Pathology." Toxicologic Pathology 34, no. 3 (April 2006): 316–17. http://dx.doi.org/10.1080/01926230600713202.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Schafer, Ken. "Organ Weights in Toxicologic Pathology." Toxicologic Pathology 35, no. 5 (August 2007): 741. http://dx.doi.org/10.1080/01926230701595250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Yoichi, Konishi, and Fukushima Shoji. "Contemporary Issues in Toxicologic Pathology." Journal of Toxicologic Pathology 17, no. 2 (2004): 129. http://dx.doi.org/10.1293/tox.17.129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ward, Jerrold M., Jerry F. Hardisty, James R. Hailey, and C. Spencer Streett. "Peer Review in Toxicologic Pathology." Toxicologic Pathology 23, no. 2 (March 1995): 226–34. http://dx.doi.org/10.1177/019262339502300218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Denlinger, Robert H. "Toxicologic Pathology of the Liver." Toxicologic Pathology 23, no. 6 (November 1995): 747–49. http://dx.doi.org/10.1177/019262339502300614.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Popp, James A. "Toxicologic Pathology of the Liver." Toxicologic Pathology 24, no. 1 (January 1996): 3. http://dx.doi.org/10.1177/019262339602400102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Morton, Laura Dill. "Training in Veterinary Toxicologic Pathology." Toxicologic Pathology 24, no. 2 (March 1996): 262–63. http://dx.doi.org/10.1177/019262339602400216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Stula, Edwin F. "The Evolution of Toxicologic Pathology." Toxicologic Pathology 25, no. 6 (November 1997): 658–59. http://dx.doi.org/10.1177/019262339702500627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Alden, Carl. "Controversial Issues in Toxicologic Pathology." Toxicologic Pathology 26, no. 3 (May 1998): 315. http://dx.doi.org/10.1177/019262339802600302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Iatropoulos, Michael J. "Endocrine considerations in toxicologic pathology." Experimental and Toxicologic Pathology 45, no. 7 (January 1994): 391–410. http://dx.doi.org/10.1016/s0940-2993(11)80365-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Deschl, U., and U. Bach. "Enzymatic catalysis in toxicologic pathology." Applied Catalysis A: General 221, no. 1-2 (November 2001): 159–69. http://dx.doi.org/10.1016/s0926-860x(01)00806-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Bolon, Brad, and Wanda M. Haschek. "The Exposome in Toxicologic Pathology." Toxicologic Pathology 48, no. 6 (March 19, 2020): 718–20. http://dx.doi.org/10.1177/0192623320912403.

Full text

Abstract:

The “exposome” is an individual’s lifetime spectrum of chemical exposures beginning at conception. An exposome includes general external influences such as pollution and weather; external individual-specific factors (diet, infections, self-selected chemical intake); and internal individual-specific constituents (metabolic byproducts, microbiome derivatives, inflammatory mediators, stress hormones, etc). The exposome paradigm is inherent in animal toxicity testing because laboratory studies are designed so that subjects share a common exposure history encompassing not only exposure(s)/treatment(s) but also other chemical sources (eg, air, bedding, food, water). Toxicologic pathologists should remember that some differences in responsiveness to a test article may reflect subtle differences in individual exposomes of seemingly equivalent test animals. Translation of toxicity data obtained in tests of genetically inbred animals maintained under controlled environmental conditions to produce quasi-identical exposomes at best offers only approximate guidance regarding potential responses in genetically heterogeneous human populations who live in many environmental settings and thus have divergent, complex exposomes.

APA, Harvard, Vancouver, ISO, and other styles

34

Hukkanen, Renee R., Noel Dybdal, Niraj Tripathi, Patricia V. Turner, and Sean P. Troth. "Scientific and Regulatory Policy Committee Points to Consider*: The Toxicologic Pathologist’s Role in the 3Rs." Toxicologic Pathology 47, no. 7 (October 2019): 789–98. http://dx.doi.org/10.1177/0192623319859261.

Full text

Abstract:

Pathologists are trained medical professionals with special expertise in diagnostics, research, and pathophysiology. In these roles, pathologists are well qualified and positioned to engage in conversations about animal use replacement, reduction, and refinement (3Rs), thereby championing the guiding principles of the 3Rs. In particular, toxicology or nonclinical safety assessment is an important area where the discipline of toxicologic pathology can have a critical role in adopting 3Rs principles. As such, a working group of the Society of Toxicologic Pathology Scientific and Regulatory Policy Committee was formed to investigate and summarize some of the areas where veterinary pathologists working in the field of toxicology can increase involvement and impact on 3Rs. This “Points to Consider” publication provides an overview of areas within toxicology where the veterinary pathologist’s perspective may maximize animal value, including refinement of study design, optimizing sample collection, the development of 3Rs focused regulatory policy, and humane end point determination.[Box: see text]

APA, Harvard, Vancouver, ISO, and other styles

35

Shockley, Keith R., and Grace E. Kissling. "Statistical Guidance for Reviewers of Toxicologic Pathology." Toxicologic Pathology 46, no. 6 (July 2, 2018): 647–52. http://dx.doi.org/10.1177/0192623318785097.

Full text

Abstract:

Study design, statistical analysis, interpretation of results, and conclusions should be a part of all research papers. Statistics are integral to each of these components and are therefore necessary to evaluate during manuscript peer review. Research published in Toxicological Pathology is often focused on animal studies that may seek to compare defined treatment groups in randomized controlled experiments or focus on the reliability of measurements and diagnostic accuracy of observed lesions from preexisting studies. Reviewers should distinguish scientific research goals that aim to test sufficient effect size differences (i.e., minimizing false positive rates) from common toxicologic goals of detecting a harmful effect (i.e., minimizing false negative rates). This journal comprises a wide range of study designs that require different kinds of statistical assessments. Therefore, statistical methods should be described in enough detail so that the experiment can be repeated by other research groups. The misuse of statistics will impede reproducibility.

APA, Harvard, Vancouver, ISO, and other styles

36

van Tongeren, Susan, Jane A. Fagerland, Michael W. Conner, Kelly Diegel, Kevin Donnelly, Branka Grubor, Alric Lopez-Martinez, et al. "The Role of the Toxicologic Pathologist in the Biopharmaceutical Industry." International Journal of Toxicology 30, no. 5 (August 30, 2011): 568–82. http://dx.doi.org/10.1177/1091581811413304.

Full text

Abstract:

Toxicologic pathologists contribute significantly to the development of new biopharmaceuticals, yet there is often a lack of awareness of this specialized role. As the members of multidisciplinary teams, toxicologic pathologists participate in all aspects of the drug development process. This review is part of an initiative by the Society of Toxicologic Pathology to educate scientists about toxicologic pathology and to attract junior scientists, veterinary students, and veterinarians into the field. We describe the role of toxicologic pathologists in identifying candidate agents, elucidating bioactive pathways, and evaluating efficacy and toxicity in preclinical animal models. Educational and specialized training requirements and the challenges of working in a global environment are discussed. The biopharmaceutical industry provides diverse, challenging, and rewarding career opportunities in toxicologic pathology. We hope that this review promotes understanding of the important role the toxicologic pathologist plays in drug development and encourages exploration of an important career option.

APA, Harvard, Vancouver, ISO, and other styles

37

Kuper, C. Frieke, and Maarten C. Bosland. "Victor Feron, A life dedicated to toxicology and toxicologic pathology." Food and Chemical Toxicology 125 (March 2019): 438. http://dx.doi.org/10.1016/j.fct.2019.01.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Turner, Oliver C., Brian Knight, Aleksandra Zuraw, Geert Litjens, and Daniel G. Rudmann. "Mini Review: The Last Mile—Opportunities and Challenges for Machine Learning in Digital Toxicologic Pathology." Toxicologic Pathology 49, no. 4 (February 16, 2021): 714–19. http://dx.doi.org/10.1177/0192623321990375.

Full text

Abstract:

The 2019 manuscript by the Special Interest Group on Digital Pathology and Image Analysis of the Society of Toxicologic pathology suggested that a synergism between artificial intelligence (AI) and machine learning (ML) technologies and digital toxicologic pathology would improve the daily workflow and future impact of toxicologic pathologists globally. Now 2 years later, the authors of this review consider whether, in their opinion, there is any evidence that supports that thesis. Specifically, we consider the opportunities and challenges for applying ML (the study of computer algorithms that are able to learn from example data and extrapolate the learned information to unseen data) algorithms in toxicologic pathology and how regulatory bodies are navigating this rapidly evolving field. Although we see similarities with the “Last Mile” metaphor, the weight of evidence suggests that toxicologic pathologists should approach ML with an equal dose of skepticism and enthusiasm. There are increasing opportunities for impact in our field that leave the authors cautiously excited and optimistic. Toxicologic pathologists have the opportunity to critically evaluate ML applications with a “call-to-arms” mentality. Why should we be late adopters? There is ample evidence to encourage engagement, growth, and leadership in this field.

APA, Harvard, Vancouver, ISO, and other styles

39

Pulido, Olga. "Domoic Acid Toxicologic Pathology: A Review." Marine Drugs 6, no. 2 (May 28, 2008): 180–219. http://dx.doi.org/10.3390/md6020180.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Ettlin, Robert A., and Joel R. Leininger. "Toxicologic Pathology in the New Millennium." Toxicologic Pathology 30, no. 1 (January 2002): 160–63. http://dx.doi.org/10.1080/01926230252824888.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kerlin, Roy. "A Regulatory Forum for Toxicologic Pathology." Toxicologic Pathology 35, no. 3 (April 2007): 449. http://dx.doi.org/10.1080/01926230701322135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

D'Andrea, G. H. "Book Review: Handbook of Toxicologic Pathology." Veterinary Pathology 40, no. 4 (July 2003): 474. http://dx.doi.org/10.1354/vp.40-4-474.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Nagano, Kasuke, Makoto Enomoto, Katuhiko Yamanouchi, Shigetoshi Aiso, Taku Katagiri, and Michio Matumoto. "TOXICOLOGIC PATHOLOGY OF UPPER RESPIRATORY TRACT." Journal of Toxicologic Pathology 1, no. 2 (1988): 115–27. http://dx.doi.org/10.1293/tox.1.115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Wolf, Douglas C. "Quantitative Toxicologic Pathology-Methods and Interpretation." Journal of Toxicologic Pathology 14, no. 4 (2001): 319. http://dx.doi.org/10.1293/tox.14.319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Maronpot, Robert R., and Maria L. Z. Dagli. "Contemporary activities of Toxicologic Pathology Societies." Journal of Toxicologic Pathology 33, no. 1 (2020): 57–63. http://dx.doi.org/10.1293/tox.2019-0000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hashimoto, K. "Book Review: Fundamentals of Toxicologic Pathology." Human & Experimental Toxicology 17, no. 7 (July 1998): 409. http://dx.doi.org/10.1177/096032719801700709.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Nold, James B. "Registry of Toxicologic Pathology for Animals." Toxicologic Pathology 23, no. 5 (September 1995): 622–23. http://dx.doi.org/10.1177/019262339502300509.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Milone, Michael C. "Handbook of Toxicologic Pathology, 2nd ed." Human Pathology 33, no. 9 (September 2002): 947. http://dx.doi.org/10.1016/s0046-8177(02)70004-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Mann, Peter C., John Vahle, Charlotte M. Keenan, Julia F. Baker, Alys E. Bradley, Dawn G. Goodman, Takanori Harada, et al. "International Harmonization of Toxicologic Pathology Nomenclature." Toxicologic Pathology 40, no. 4_suppl (May 25, 2012): 7S—13S. http://dx.doi.org/10.1177/0192623312438738.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Ettlin, Robert A. "Toxicologic Pathology in the 21st Century." Toxicologic Pathology 41, no. 5 (November 9, 2012): 689–708. http://dx.doi.org/10.1177/0192623312466192.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!